Blood test for high-grade upper tract urothelial cancer
Part of Cancer, Kidney & urinary clinical trials.
This study looks at a blood test that finds tiny pieces of tumor DNA. It may help doctors understand how well treatment is working for people with high-grade upper tract urothelial cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with high-grade upper tract urothelial cancer.
- You are planning to receive systemic therapy (medicine that travels through your body) or have surgery to remove the cancer.
- You are willing to have a blood test called Signatera to check for tumor DNA.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a simple blood test that looks for cancer DNA in your blood. The goal is to see if it can accurately detect muscle-invasive bladder cancer or upper tract urothelial cancer.
This study tests whether a simple urine test can accurately identify cancer in the bladder, ureters (tubes between kidneys and bladder), or renal pelvis (part of the kidney). You would provide urine samples before your planned surgery, and researchers will compare the urine test results to your actual tissue diagnosis after surgery.
This study looks at whether a blood test called Signatera can help find small amounts of cancer DNA after surgery for early-stage endometrial cancer. The goal is to see if this test can help guide treatment decisions and improve outcomes.
This study tests a new urine test that may help find cancers of the urinary tract (like bladder or kidney cancer) in people who have blood in their urine. If the test works well, it could provide a simpler way to check for cancer compared to standard procedures.
This study checks tumor DNA found in blood and urine to see who is at higher risk of the cancer coming back after surgery. It may help doctors identify “minimal residual disease,” meaning tiny amounts of cancer that can remain after treatment.
This trial is for people diagnosed with a rare type of cancer in the upper urinary tract (UTUC). Researchers hope to learn more about this condition and find better ways to treat it.
Hear when a new Upper Tract Urothelial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.